Clinical trial
High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease
NCT05103397 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease
- Lead sponsor
- Ain Shams University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 16, 2021
- Completion date
- January 30, 2022
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia